Purpose: To 1) evaluate the embryotoxic effects of hydrogen peroxide on mouse embryo development and 2) examine if pentoxifylline can reverse hydrogen peroxide induced embryotoxicity.
Methods: Prospective in vitro study examining the effects of varying concentrations of hydrogen peroxide and pentoxifylline on the blastocyst development rate alone as well as in combination.
Results: A dose-dependent decrease in % BDR was seen with increasing concentrations of H2O2. High concentrations of hydrogen peroxide (> 60 μM) were embryotoxic. Pentoxifylline (500 μM) was able to reduce the embryotoxic effect of hydrogen peroxide. Percent blastocyst development rate increased from 44% in hydrogen peroxide alone to 85% in hydrogen peroxide and pentoxifylline coincubation.
Conclusions: Pentoxifylline may be beneficial in reducing hydrogen peroxide induced embryo damage and improve IVF outcome. Patients with endometriosis-associated infertility may benefit from the use of pentoxifylline without significantly affecting embryo development.
The Full Text of this article is available as a PDF
These references are in PubMed. This may not be the complete list of references from this article.
1. Sharma RK, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Biol. 2004;3:177–199. doi: 10.1111/j.1447-0578.2004.00068.x. [Cross Ref] 2. Guerin P, El Mouatassim S, Menezo Y. Oxidative stress and protection against reactive oxygen species in the pre-implantation embryo and its surroundings. Hum Reprod Update. 2001;7:175–189. doi: 10.1093/humupd/7.2.175. [PubMed] [Cross Ref] 3. Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod. 2002;17:426–431. [PubMed] 4. Attaran M, Pasqualotto E, Falcone T, et al. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int J Fertil Womens Med. 2000;45:314–320. [PubMed] 5. Pasqualotto EB, Agarwal A, Sharma RK, et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil Steril. 2004;81:973–976. doi: 10.1016/j.fertnstert.2003.11.021. [PubMed] [Cross Ref] 6. Bedaiwy MA, Goldberg JM, Falcone T, Singh M, Nelson D, Azab H, Sharma RK. Relationship between oxidative stress and embryotoxicity of hydrosalpingeal fluid. Hum Reprod. 2002;17:601–604. [PubMed] 7. Szcyzepanska M, Kozlik J, Skrzypczak J, Mikolsajczyk M. Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril. 2003;79:1288–1293. [PubMed] 8. Bedaiwy MA, Falcone T, Mohamed MS, et al. Differential growth of human embryos in vitro: Role of reactive oxygen species. Fertil Steril. 2004;82:593–600. doi: 10.1016/j.fertnstert.2004.02.121. [PubMed] [Cross Ref] 9. Yang HW, Hwang KJ, Kwon HC. Detection of reactive oxygen species (ROS) and apoptosis in human fragmented embryos. Hum Reprod. 1998;13:998–1002. doi: 10.1093/humrep/13.4.998. [PubMed] [Cross Ref] 10. Nasr-Esfahani MH, Aitken RJ, Johnson MH. Hydrogen peroxide levels in mouse oocytes and early cleavage stage embryos developed in vitro or in vivo. Development. 1990;109:501–507. [PubMed]
11. Ward A, Stephen PC. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987;34:50–97.
12. Steinleitner A, Lambert H, Roy S. Immunomodulation with pentoxifylline abrogates macrophage-mediated infertility in an in vivo model: A paradigm for a novel approach to the treatment of endometriosis-associated subfertility. Fertil Steril. 1991;55:26–31. [PubMed] 13. Steinleitner A, Lambert H, Suarez M. Immunomodulation in the treatment of endometriosis-associated subfertility: Use of pentoxifylline to reverse the inhibition of fertilization by surgically induced endometriosis in a rodent model. Fertil Steril. 1991;55:975–979. [PubMed]
14. Juan B, Montserrat C, Francisco F. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: A pilot randomized clinical trial. Hum Reprod. 1997;12:1046–1050.
15. Shanti A, Santanam N, Morales AJ, Parthasarathy S, Murphy AA. Autoantibodies to markers of oxidative stress are elevated in women with endometriosis. Fertil Steril. 1999;71:1115–1118. doi: 10.1016/S0015-0282(99)00145-4. [PubMed] [Cross Ref]